Artificial intelligence for glaucoma.

This is a protocol for a Cochrane Review (diagnostic). The objectives are as follows: To determine the accuracy of artificial intelligence (AI) algorithms as a diagnostic tool for glaucoma compared with human graders in a community or secondary care setting. Secondary objectives To compare the performance of different AI algorithms in the diagnosis of glaucoma To explore other potential causes of heterogeneity in the diagnostic performance compared with human graders, using subgroup analysis of the following characteristics: Clinical setting in which the test is used (the general population in the community versus people referred to secondary care); Study design (studies enroling consecutive participants in the same setting versus multicentre registries and public databases); Characteristics of the population (age according to quartiles, sex, symptomatic versus asymptomatic), when sufficient data are available; Prevalence of glaucoma in the training and test sets (< 5% versus ≥ 5%), since sensitivity and specificity may depend on disease prevalence [17]; Severity of glaucoma; Core AI method used (neural networks, random forests, support vector machines, or others); Size of the dataset from which performance data were collected (< 1000 versus ≥ 1000 total unique participants); Modalities of input data for the AI algorithms (imaging data, visual fields, clinical parameters, or any combination), particularly as their accessibility and affordability may vary across different settings.